Elisa Using Tumor Lysates

Raji Cell Lysates

GWB-3F8843 0.2 mg Ask for price

Human IgG antibody Laboratories manufactures the elisa using tumor lysates reagents distributed by Genprice. The Elisa Using Tumor Lysates reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tumor elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Using Group: Tumor Lysates

Daudi Cell Lysates

5x0.2mg
EUR 625

Raji Cell Lysates

0.2mg
EUR 160

Raji Cell Lysates

5x0.2mg
EUR 625

Tricostatin A (TSA) Treated And Untreated Cell Lysates

100 µg treated + 100 µg untreated
EUR 107.12

True Blue

5.0mg
EUR 595

True Blue

10mg Ask for price
Description: True Blue

True Blue

1g Ask for price
Description: True Blue

Tumor Lysates information

Rabbit polyclonal using eIF2 alpha (Ser51) antibody(Phospho-specific)

TA312128 100 µl Ask for price

Skin Tumor Lysate

1337 0.1 mg
EUR 304.8
Description: Skin tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Skin Tumor Lysate

MBS151601-01mg 0.1mg
EUR 260

Skin Tumor Lysate

MBS151601-5x01mg 5x0.1mg
EUR 1140

Lung Tumor Lysate

MBS151668-01mg 0.1mg
EUR 260

Lung Tumor Lysate

MBS151668-5x01mg 5x0.1mg
EUR 1140

Liver Tumor Lysate

1330 0.1 mg
EUR 304.8
Description: Liver tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Liver Tumor Lysate

MBS151608-01mg 0.1mg
EUR 260

Liver Tumor Lysate

MBS151608-5x01mg 5x0.1mg
EUR 1140

Brain Tumor Lysate

MBS151610-01mg 0.1mg
EUR 260

Brain Tumor Lysate

MBS151610-5x01mg 5x0.1mg
EUR 1140

Ovary Tumor Lysate

MBS151654-01mg 0.1mg
EUR 260

Ovary Tumor Lysate

MBS151654-5x01mg 5x0.1mg
EUR 1140

Colon Tumor Lysate

MBS151700-01mg 0.1mg
EUR 260

Colon Tumor Lysate

MBS151700-5x01mg 5x0.1mg
EUR 1140

Rectum Tumor Lysate

1336 0.1 mg
EUR 304.8
Description: Rectum tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Spleen Tumor Lysate

1339 0.1 mg
EUR 304.8
Description: Spleen tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.